![Jianping Lu and Otto Zhou sit outside of a building on the UNC-Chapel Hill campus.](https://unclineberger.org/wp-content/uploads/sites/867/2021/05/Lu-Zhou-feature-600x400.jpeg)
May 18, 2021
A sharper image
UNC researchers Jianping Lu and UNC Lineberger's Otto Zhou have spent the last two decades refining technology that makes X-ray machines smaller, faster, safer and produce clearer images.
May 18, 2021
UNC researchers Jianping Lu and UNC Lineberger's Otto Zhou have spent the last two decades refining technology that makes X-ray machines smaller, faster, safer and produce clearer images.
May 11, 2021
The University of North Carolina at Chapel Hill is recognizing 118 UNC Lineberger staff and faculty members who will be celebrating a service milestone this year.
May 7, 2021
Lisa A. Carey, MD, FASCO, co-chaired two sessions and presented a talk at the European Society for Medical Oncology’s Breast Cancer Virtual Congress.
May 4, 2021
Ralph S. Baric, PhD, has been elected to the National Academy of Sciences, one of the highest distinctions for a scientist in the United States.
May 3, 2021
Lawrence Marks, MD, and colleagues published a comprehensive review highlighting the optimal ways that focused, high-dose radiation can be delivered to various types of tumors while sparing normal tissue and mitigating long-term side effects.
April 20, 2021
The Triangle Business Journal honored Ralph Baric, PhD, Lauren Lux, MSW, LCSW, and Andrew Smitherman, MD, MSc, MPH, during the 2021 Health Care Heroes award ceremony.
April 14, 2021
A pilot program from the Mary Anne Long Patient and Family Resource Center helped several hundred cancer patients during the first seven months of the pandemic using virtual resources.
April 5, 2021
Six rising seniors at the UNC School of Nursing were named 2021 UNC Lineberger-Sylvia Lauterborn and Warren Trent Piver Oncology Nursing Fellows.
March 26, 2021
Soon after her first round of chemotherapy in March 2020, Brighid Willis, her family and care team had to pivot quickly due to the COVID-19 pandemic.
March 21, 2021
Thomas Alexander, MD, MPH, and colleagues published findings from a study that found pairing venetoclax with low-dose navitoclax and chemotherapy had promising efficacy in patients with difficult to treat leukemia and lymphoma.